Canada markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
273.28+3.24 (+1.20%)
At close: 4:00PM EDT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
2016-12-31
Total Revenue
14,487,300
14,377,900
13,452,900
12,273,900
11,448,800
Cost of Revenue
1,742,600
1,955,400
1,816,300
1,630,000
1,478,700
Gross Profit
12,744,700
12,422,500
11,636,600
10,643,900
9,970,100
Operating Expenses
Research Development
2,356,000
2,280,600
2,597,200
2,253,600
1,973,300
Selling General and Administrative
2,344,600
2,374,700
2,106,300
1,935,500
1,947,900
Total Operating Expenses
5,398,700
5,386,800
5,635,800
5,116,100
4,317,000
Operating Income or Loss
7,346,000
7,035,700
6,000,800
5,527,800
5,653,100
Interest Expense
202,100
187,400
200,600
250,800
260,000
Total Other Income/Expenses Net
8,600
157,600
-13,100
-226,700
-523,500
Income Before Tax
7,244,200
7,125,900
5,899,600
5,128,800
4,933,000
Income Tax Expense
1,225,600
1,158,000
1,425,600
2,458,700
1,237,300
Income from Continuing Operations
5,984,600
5,888,500
4,474,000
2,670,100
3,695,700
Net Income
5,926,800
5,888,500
4,430,700
2,539,100
3,702,800
Net Income available to common shareholders
5,926,800
5,888,500
4,430,700
2,539,100
3,702,800
Basic EPS
-
31.47
21.63
11.94
16.96
Diluted EPS
-
31.42
21.58
11.92
16.93
Basic Average Shares
-
187,100
204,900
212,600
218,400
Diluted Average Shares
-
187,400
205,300
213,000
218,800
EBITDA
-
7,993,900
7,116,800
6,460,600
5,875,700